Results 141 to 150 of about 786,893 (341)
Non-REM sleep in major depressive disorder
Disturbed sleep is a key symptom in major depressive disorder (MDD). REM sleep alterations are well described in the current literature, but little is known about non-REM sleep alterations.
Leonore Bovy+7 more
doaj
Temporal discounting in major depressive disorder. [PDF]
BACKGROUND: Major depressive disorder (MDD) is associated with abnormalities in financial reward processing. Previous research suggests that patients with MDD show reduced sensitivity to frequency of financial rewards.
B. J. Sahakian+16 more
core +1 more source
Lycium barbarum glycopeptide (LBGP), which is further extracted from Lycium barbarum polysaccharides, exhibits significant protective effects against neomycin‐induced hearing dysfunction including oxidative stress in cochlea and loss of key cells in cochlea.
Yunhao Wu+12 more
wiley +1 more source
Ignacio Basurte-Villamor,1 Pablo Vega,2 Carlos Roncero,3– 5 José Martínez-Raga,6 Lara Grau-López,7– 10 Lourdes Aguilar,3– 5 Marta Torrens,11 Nestor Szerman12 1Department of Psychiatry and Behavioral Health, Clínica López Ibor, Madrid, Spain; 2Institute ...
Basurte-Villamor I+7 more
doaj
The pattern of structural brain alterations associated with major depressive disorder (MDD) remains unresolved. This is in part due to small sample sizes of neuroimaging studies resulting in limited statistical power, disease heterogeneity and the ...
L. Schmaal+67 more
semanticscholar +1 more source
D‐galactose (D‐gal) induced inner ear hair cell senescence by inhibiting TFEB transcription. RONIN/HCF1 promotes TFEB transcription to prevent cochlear HCs from D‐gal‐induced senescence through autophagy activation. Abstract Age‐related hearing loss is characterized by senescent inner ear hair cells (HCs) and reduced autophagy.
Yongjie Wei+18 more
wiley +1 more source
Desvenlafaxine in the treatment of major depressive disorder
Maria Teresa C Lourenco1, Sidney H Kennedy1,21Department of Psychiatry, University Health Network, Toronto; 2Department of Psychiatry, University of Toronto, Toronto, CanadaAbstract: Major depressive disorder (MDD) is among the most incapacitating ...
Maria Teresa C Lourenco1+1 more
doaj
Elyas Adamsu Basha,1 Bethelehem Taye Mengistu,1 Nigus Alemnew Engidaw,1 Abate Dargie Wubetu,1 Assalif Beyene Haile2 1Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Midwifery, College of ...
Basha EA+4 more
doaj
Background To assess the reliability and validity of Patient Health Questionnaire-9 (PHQ-9) for patients with major depressive disorder (MDD) and to assess the feasibility of its use in psychiatric hospitals in China. Methods One hundred nine outpatients
Yue Sun+5 more
semanticscholar +1 more source
Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway
This study have elucidated the brain‐targeted delivery pathways and transport mechanisms of nanoodors by various technical means and found that the olfactory pathway is main one. Nanoodors can rapidly deliver drugs to the central nervous system via olfactory pathway and will hopefully solve the delivery challenges for various types of central nervous ...
Wei Zhang+8 more
wiley +1 more source